Navigation Links
ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
Date:4/30/2009

lutions. "Our teams have been working exceptionally hard to develop solutions that meet our client needs, while ensuring they are simple and easy for sites to adopt and use. The credit really should go to them," added DePaolis.

In today's technology-driven clinical trials environment, sponsors and sites are required to use dozens of new technologies for every study they conduct, typically having to remember different user credentials for each technology. The Clinical Trial Portal helps streamline and systematize clinical trial workflow between sponsors and sites providing one userID and one URL for all of the studies they conduct while providing detailed and dashboard level reporting to help manage the entire process at the user, site, study and enterprise level.

About ePharmaSolutions, Inc.

ePharmaSolutions is a leading provider of technology-based clinical services that help improve the way sites are selected, trained, activated and supported to commence clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 143,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world. ePharmaSolutions is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com. For an interactive demonstration of the Clinical Trial Portal go to http://courses.epharmasolutions.com/diasomedemo/shortdemo.htm.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)..., Nov. 21 An urgent need for new m... the developing world has prompted a growing numbe...n-profit product development partnerships (PDPs), ... noted today in a symposium at the 58th annual mee...and Hygiene (ASTMH), these collaborations are open...
(Date:11/20/2009)...a., Nov. 20 Unilens Visi...change: UVI), which develops, licenses, manufactur...es, today reported its operating results for the f..., Net sales excluding royalty income, were $1,68...$1,761,526 reported in the previous year first qua...
(Date:11/20/2009)... Ill., Nov. 20 /PRNewswire-FirstCall/ -- Landau... for the fiscal fourth quarter and full year of 20...The company will host a conference call for invest...tern Time. Investors may access the live call by d...Canada), or 480-629-9835 (international callers), ...
Breaking Medicine Technology:ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Nanoresearchers challenge dogma in protein transportation in cells 10001 1Nanoresearchers challenge dogma in protein transportation in cells 10001 2American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 1American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 2American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 3American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 4American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 5FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 57798 1FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 57798 2FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 57798 3
...d AMSTERDAM, December 12 ,Agendia, a world leader ...ammaPrint(R),s ability to predict response to neoa... Laura van ,t Veer, from the Netherlands Cancer In...o Breast Cancer Symposium (SABCS) during the,sessi...isions. The study,analyzed the association between...
...cell AG (VSE: ICLL) today,announced the execution ...t of,Health and Human Services (HHS). The agreeme...tercell,s Pandemic Influenza program. , Inte...atch System that,includes an immunostimulant patch...emic Influenza vaccine (manufactured by Solvay Bio...
Other Medicine Technology:Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer 2USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS) 2USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS) 3
(Date:11/23/2009)... Great Lakes Orthodontics, Ltd. (Tonawa...ental cleaner powerful enough to kill more than 99...mouthguards. , Tonawanda,... by Oklahoma State University found that mouthguar...teria and microorganisms from staph to strep to pn...
(Date:11/22/2009)...own to stimulate blood vessel growth has now been ... the development of polyps that characterize one o...ohns Hopkins researchers suggests. The finding giv...erapies to treat this form of the disease, which t...ic sinusitis, a constant irritation and swelling o...
(Date:11/22/2009)... The Onder Law Firm’s attorneys a...families of those who may have experienced heart a...er taking XOLAIR. , St. L...w Firm are among attorneys offering free XOLAIR c...art attack and stroke. The attorneys of the Onder...
(Date:11/22/2009)...s surface, bacteria are abundant, diverse and cons...t the University of California, San Diego School o...ng on the skin surface trigger a pathway that prev...se germs are actually good for us," said Richard L...rics, chief of UCSD,s Division of Dermatology and ...
(Date:11/22/2009)... can help keep eating under control, expert says ,...he holiday season means you,ll be faced with a see...me people simply give in and eat too much, others ... are ways to navigate between overindulgence and d... Nutrition Consult Services at Brigham and Women,s...
Breaking Medicine News(10 mins):Health News:DentaSOAK Dental Cleaner Reduces Infection Risk Linked to Mouthguards 2Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 2Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 3Health News:The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review 2Health News:Surface bacteria maintain skin's healthy balance 2Health News:Go Healthy, Not Hungry for Holiday Eating 2
...HealthCentral Network, Inc. ( http://www.HealthCen...today announced a collaboration leveraging,APF,s s... and support,resource with HealthCentral.com,s mul...g on the topic of pain written by,APF,s Executive ...
...n compliance services resulting in increa... Sept. 18 Amcat, a leading provider of,intelligen...that it has,signed a partner agreement with Grypho... compliance solution for Amcat,customers involved ...
...TM) On Demand Entertainment Package for a More... LodgeNet Deployment in a Children,s Hospital, SI... Entertainment Corporation (Nasdaq: LNET ) and Ch..., the company,s,first ever in a children,s hospita...
...nce toward rapid testing for pre-natal detection o...ve an abnormal number of chromosomes. , In a stud...nal, Analytical Chemistry, Stanford University bio...isting pre-natal tests depend on a technique terme...
...c. (OTCBB: PVCT) announced preliminary results of ...atment of metastatic melanoma, the most aggressive...l side effects, significant efficacy and bystander...lia. , In the study, Provecta was injected once i...
... in how they respond to treatment, but now researc...rapy at the University of Arkansas for Medical Sci...e activity could predict high-risk cases and poten...a genetic profile to chart the severity of the dis...
Other Medicine News:Health News:The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain 2Health News:The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain 3Health News:Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities 2Health News:Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities 3Health News:LodgeNet Deploys Customized 'Kid Friendly' Solution With Children's Hospital of Pittsburgh of UPMC 2Health News:LodgeNet Deploys Customized 'Kid Friendly' Solution With Children's Hospital of Pittsburgh of UPMC 3Health News:Toward a faster prenatal test for Down syndrome 2Health News:Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study 2Health News:Gene profiling can single out the worst cases of multiple myeloma and guide therapy 2Health News:Gene profiling can single out the worst cases of multiple myeloma and guide therapy 3
...ami is a universal hook, rod, and screw system des...edures. The Moss Miami system utilizes a low profi...ial screws, and a dual closure mechanism. The load... proper tension band principle to be applied when ...
BLF21A Alarm Model
Microflo DSP
Oxyflo 2000
Medicine Products: